Roth Boosts PT on Concert Pharma (CNCE) to $22 Following; Deuterium Platform, Partnerships Will Bolster Gains

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/5/2026

1. KRG
2. SPY
3. ALAR
4. SKA-B
5. PBA
6. CCH:LN
7. META
8. CCHGY
9. PRY:IM
10. PRYMY

Go back to Roth Boosts PT on Concert Pharma (CNCE) to $22 Following; Deuterium Platform, Partnerships Will Bolster Gains

Concert Pharma (CNCE) Misses Q1 EPS by 4c

May 8, 2015 8:56 AM EDT

Concert Pharma (NASDAQ: CNCE) reported Q1 EPS of ($0.48), $0.04 worse than the analyst estimate of ($0.44). Revenue for the quarter came in at $1.3 million versus the consensus estimate of $2.7 million.

For earnings history and earnings-related data on Concert Pharma (CNCE) click here.

... More